NASDAQ
AN2 Therapeutics, Inc. (ANTX) has a current ratio of 6.87x as of Monday, May 25, 2026. This represents a 42.39% decrease compared to its 12-month average of 11.93x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.